Skip to main content

Table 2 Age standardized study population characteristic by subtypes of cases in means (standard deviations) or percents, Cancer of the Prostate Sweden Study

From: Total antioxidant intake and prostate cancer in the Cancer of the Prostate in Sweden (CAPS) study. A case control study

  Fatal Advanced Localized High grade Low grade
N 307 499 1020 231 693
FRAP diet (mmol/d) 21.6 (7.9) 22.5 (8.9) 22.2 (8.1) 21.3 (8.0) 22.3 (8.0)
FRAP fruit/vegs (mmol/d) 3.5 (1.9) 3.4 (1.7) 3.5 (1.7) 3.6 (2.0) 3.4 (1.6)
FRAP suppl. (mmol/d) 0.7 (1.2) 0.8 (1.4) 0.9 (1.4) 0.9 (1.3) 0.8 (1.4)
Age 67.0(7.3) 68.6 (7.4) 66.0 (7.1) 68.3 (7.4) 65.4 (7.0)
BMI 26 (3) 26 (3) 26 (3) 26 (3) 26 (4)
Current smokers (%) 14 13 10 12 10
Never smokers (%) 42 39 39 41 38
0–9 years education (%) 53 51 44 48 44
10–12 years education (%) 37 41 40 40 41
13+ yrs education (%) 10 8 17 13 16
Energy kcal/d) 2363 (701) 2334(681) 2270 (630) 2387(655) 2234 (624)
Coffee (cups/day) 3.1 (1.8) 3.2(2.0) 3.1 (1.9) 3.0 (1.9) 3.1 (1.8)
Tea (cups/day) 0.5 (0.8) 0.5 (0.9) 0.7 (1.1) 0.6 (0.8) 0.7 (1.1)
Chocolate (serv./d) 0.2 (0.3) 0.2 (0.3) 0.2 (0.2) 0.2 (0.2) 0.2 (0.2)
Berries (serv./d) 0.2 (0.3) 0.2 (0.2) 0.2 (0.3) 0.2 (0.3) 0.1 (0.2)
Boiled potatoes (serv./d) 0.6(0.4 0.6 (0.4) 0.6 (0.4) 0.6 (0.3) 0.6 (0.4)
Multivitamin use (%) 21 22 21 29 20
Vitamin C suppl. use (%) 12 15 15 16 14
Vitamin E suppl. use (%) 3 3 4 3 5
Calcium (mg/d) 1241(406) 1222 (390) 1188 (363) 1213 (381) 1193 (363)
Zinc (mg/d) 11.5 (1.9) 11.5 (1.9) 11.6 (1.9) 11.6 (1.9) 11.7 (1.8)
PSA at diagnosis 264 (573) 276 (665) 39 (241) 167 (364) 22 (136)
  1. Fatal prostate cancer: Death from prostate cancer through follow up. Advanced prostate cancer: M1, N1, T3 or T4 and death during follow up. Localized prostate cancer: T1 or T2 and N0/M0. High-grade prostate cancer: Gleason sum 8–10. Low-grade prostate cancer: Gleason sum 2–6